Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast

Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast

Atypical hyperplasia of the breast (AH) is associated with increased risk of subsequent invasive breast cancer, yet little is known about the etiology of AH. Insulin-like growth factor binding protein 2 (IGFBP-2) may contribute to the development of AH due to its proliferative effects on mammary tis...

Full description

Bibliographic Details
Main Authors: Catsburg, Chelsea, Gunter, Marc J., Tinker, Lesley, Chlebowski, Rowan T., Pollak, Michael, Strickler, Howard D., Cote, Michele L., Page, David L., Rohan, Thomas E.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464590/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464590/

Similar Items